Clinical Social Workers in Roxbury Crossing, MA Accepting Medicare

11 Clinical Social Workers found. Showing 1 - 11

Mrs. Brenda Louise Daley, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1125 Tremont St, Roxbury Crossing, Roxbury Crossing, MA 02120 Phone: 617-427-1000    Fax: 617-989-3125

Ms. Amy L. Venezia, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 69 Alleghany St, Roxbury Crossing, MA 02120 Phone: 617-524-4620    Fax: 617-983-1658

Beatrice Antoine, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 69 Alleghany St, Roxbury Crossing, MA 02120 Phone: 857-276-8959

Joanna Dorota Kolakowska Bolalek, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 127 Fisher Ave, Roxbury Crossing, MA 02120 Phone: 857-245-5679

Chandni Shroff, MS Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 69 Alleghany St, Roxbury Crossing, MA 02120 Phone: 617-254-0964

Elizabeth Kia Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 71 Alleghany St, Roxbury Crossing, MA 02120 Phone: 617-254-0964

Christine Pajarillo, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1125 Tremont St, Roxbury Crossing, MA 02120 Phone: 617-989-3212    Fax: 617-989-3227

Mr. William Dain, MSW, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1125 Tremont St, Roxbury Crossing, MA 02120 Phone: 617-427-1000

Emily Stewart, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 68 Annunciation Rd, Roxbury Crossing, MA 02120 Phone: 857-308-3000

Taylor Sokol Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 71 Alleghany St, Roxbury Crossing, MA 02120 Phone: 508-259-8122

Lauren Cardoso Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 69 Alleghany St, Roxbury Crossing, MA 02120 Phone: 617-524-4620

News Archive

Medical Marijuana offers "Turnkey Collective Solution" for collectives to conform to state laws

Medical Marijuana, Inc. is the ONLY company that provides the specific solutions the government is seeking in order for all collectives and co-ops to be in total compliance with state laws and city/county ordinances. Their revolutionary patent pending Tax Remittance Card and patent pending Inventory Management System and Supply Chain Network provides all of the tools necessary for regulatory authorities and industry operators alike to manage compliance efficiently and effectively.

Patient advocacy or political ploy? Union, industry square off over dialysis initiative

This year, California dialysis clinics — and their profits — are in a powerful union's crosshairs. On Nov. 6, the Service Employees International Union-United Healthcare Workers West union hopes to deliver a stinging blow with a ballot measure designed to limit clinic profits.

Fresenius Medical Care's first-quarter net revenue up 13% to $2,882 million

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its results for the first quarter of 2010.

Mylan to acquire Bioniche Pharma for $550M

Mylan Inc. today announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan's earnings in year one, without accounting for any operational or other synergies.

Additional positive data from Ardea Biosciences' RDEA594 Phase 2 program presented at EULAR

Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.

Read more Medical News

› Verified 1 days ago